What is the Dose Response of Varying Meal Content of Fat on Postprandial Glycaemia in Children With T1DM?
NCT02371694 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2019-08-20
Summary
Background: Based on international evidence, current management of people with T1DM on intensive insulin therapy (IIT) use algorithms based on the meal carbohydrate content (MCC) to calculate the prandial insulin dose. Typically, these calculations do not take into account the protein or fat content of the meal. There is a lack of clinical advice for optimal management of high protein/fat meals due to a paucity of evidence regarding the impact of protein/fat on glycaemic control.
Objective: To determine the mean glucose excursion from fasting (measured by continuous glucose monitoring, CGMS) at each 30 minute interval over the 8 hour postprandial period for each test condition. Protein effects will be looked at in a separate parallel study in Australia.
Hypothesis: The fat content of a meal will cause a dose-response change in the postprandial glucose concentration in children with T1DM.
Research Design and Methods: Randomised cross-over study involving thirty patients. Inclusion criteria: T1DM \>1 year, aged 8-18 years, with HbA1c \<8% and BMI \<91st centile, on intensive insulin therapy. Participants will be given a test meal on 6 consecutive nights in random order; 4 test meals varying in fat content, and one 20g carbohydrate test meal with zero fat given as control meal. A CGMS will be used to assess glucose responses at 5 minute intervals for 8 hours after test meal consumption. The relationship between the fat loads in the test meals and the mean change in postprandial glucose concentration will be analysed and described.
Conclusions: This study will determine whether fat causes dose dependent response in glucose concentrations leading to refining the guidelines and possible adjustment of insulin doses for the fat content of a meal.
Conditions
- Diabetes Mellitus, Type 1
Interventions
- OTHER
-
Test drink
The intervention is a drink taken 4 hours after the evening meal insulin injection, or 10PM, whichever is later. All drinks are 116-120g in weight and similar volume. All drinks are served in a double blind fashion, apart from the 20g carbohydrate which is visibly different from other drinks in colour, texture and flavour.
Sponsors & Collaborators
-
National University of Ireland, Galway, Ireland
collaborator OTHER -
John Hunter Children's Hospital
collaborator OTHER -
Cork University Hospital
lead OTHER
Principal Investigators
-
Susan O'Connell, MD · Cork University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 8 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-02-28
- Primary Completion
- 2018-12-30
- Completion
- 2018-12-30
Countries
- Ireland
Study Locations
More Related Trials
-
Additional Insulin for High Fat/Protein in Type 1 Diabetes
NCT05152121 ·Status: COMPLETED ·Phase: NA
-
Safety and Feasibility of a Low Carbohydrate Diet in Children With Type 1 Diabetes
NCT04228822 ·Status: COMPLETED ·Phase: NA
-
Safety of Low and Very Low Carbohydrate Diets in Young Children With Type 1 Diabetes
NCT03862521 ·Status: COMPLETED ·Phase: NA
-
Timing of Pre-meal Insulin Versus Accurate Carbohydrate Counting in Youth With Type 1 Diabetes
NCT01209312 ·Status: COMPLETED ·Phase: NA
-
Prospective Study of the Impact of Insulin Pump Therapy in Young Children With Type 1 Diabetes
NCT00727220 ·Status: COMPLETED
-
Diluted Insulin in Young Children: Bigger Volumes for Smaller Patients
NCT03666065 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Low-carbohydrate Diet in Children with Type 1 Diabetes
NCT05078658 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study of Rapid-Acting Mealtime Insulin in Children and Adolescents With Newly Diagnosed Type 1 Diabetes Mellitus
NCT04157738 ·Status: COMPLETED ·Phase: PHASE4
-
Additional Insulin for Fat and Protein in Children With Diabetes Study
NCT02680054 ·Status: TERMINATED ·Phase: PHASE4
-
Lantus in the Treatment of Type 1 Diabetes Children
NCT00206401 ·Status: COMPLETED ·Phase: PHASE4
-
Lunch Time Insulin Injection by School Nurse for Poorly Controlled Diabetes
NCT00340613 ·Status: COMPLETED ·Phase: PHASE4
-
CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism
NCT02937558 ·Status: COMPLETED ·Phase: PHASE2
-
Extended Bolus for Meals in a Closed-loop System
NCT05454891 ·Status: COMPLETED ·Phase: NA
-
Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms, Pump Suspension, and Insulin Dosing in Children and Young Adolescents
NCT02714972 ·Status: COMPLETED ·Phase: PHASE2
-
The Impact of a Moderate Carbohydrate Diet in Children With Type 1 Diabetes on Hybrid Closed-loop Therapy
NCT06567158 ·Status: RECRUITING ·Phase: NA
-
Effect of Dual-wave Insulin Bolus on Postprandial Glycaemia
NCT03179280 ·Status: COMPLETED ·Phase: NA
-
Dual-wave Boluses in Children With Type 1 Diabetes Insulin Boluses in Children With Type 1 Diabetes
NCT04668612 ·Status: UNKNOWN ·Phase: NA
-
Glycaemic Load and Pre-meal Insulin Doses in Type 1 Diabetes Patients
NCT01978704 ·Status: COMPLETED ·Phase: NA
-
Insulin Bolus Required for High Fat Foods in Type 1 Diabetes
NCT02248454 ·Status: COMPLETED ·Phase: NA
-
Study of the Effects of Carbohydrate Counting
NCT01223547 ·Status: COMPLETED ·Phase: NA
-
Timing of Meal Insulin Boluses for Optimal Postprandial Glycemic Control in Type 1 Diabetes
NCT01693302 ·Status: COMPLETED ·Phase: NA
-
Normal Versus Dual Wave Insulin Bolus for High-protein Food
NCT02276859 ·Status: COMPLETED ·Phase: PHASE4
-
Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus
NCT00442767 ·Status: COMPLETED ·Phase: PHASE4
-
Hybrid Closed-Loop Control With Smart Prandial Insulin Dosing in Type 1 Diabetes
NCT04878120 ·Status: COMPLETED ·Phase: NA
-
Comparison of a Twice Daily Versus a Three Times Daily Insulin Regimen in Children With Type 1 Diabetes
NCT00522210 ·Status: COMPLETED ·Phase: NA